Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · see citing works

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463 · see citing works

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907 · see citing works

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688 · see citing works

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · see citing works

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · see citing works

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,436 · see citing works

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · see citing works

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · see citing works

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · see citing works

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109 · see citing works

COVID-19 and the cardiovascular system

Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970 · see citing works

Bats Are Natural Reservoirs of SARS-Like Coronaviruses

Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571 · see citing works

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453 · see citing works

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031 · see citing works

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778 · see citing works

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733 · see citing works

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · doi:10.1101/2020.02.03.931766 · Cited by 952 · see citing works

Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0179le · Cited by 916 · see citing works

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection

Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 903 · see citing works

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824 · see citing works

Structure analysis of the receptor binding of 2019-nCoV

Chen, Y., Guo, Y., Pan, Y., & Zhao, Z. J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.071 · Cited by 806 · see citing works

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV

Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 618 · see citing works

Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionPreprint

Diao, B., Wang, C., Wang, R., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20031120 · Cited by 489 · see citing works

Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme

Ye, M., Wysocki, J. A., William, J., Soler, M. J., Cokic, I., & BATLLE, D. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050423 · Cited by 487 · see citing works

Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters

Kuba, K., Imai, Y., Ohto‐Nakanishi, T., & Penninger, J. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.003 · Cited by 480 · see citing works

Renin-Angiotensin System Blockers and the COVID-19 Pandemic

Danser, A. H. J., Epstein, M., & BATLLE, D. C. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15082 · Cited by 457 · see citing works

The emerging role of ACE2 in physiology and disease

Hamming, I., Cooper, M. E., Haagmans, B. L., Hooper, N. M., Korstanje, R., Osterhaus, A. D. M. E., Timens, W., Turner, A., Navis, G. J., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2162 · Cited by 437 · see citing works

Myocardial infarction increases ACE2 expression in rat and humans

Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., Macdonald, P. S., Lu, L., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi114 · Cited by 423 · see citing works

Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections

Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4594 · Cited by 401 · see citing works

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

Ruiz‐Ortega, M., Rupérez, M., Esteban, V., Rodríguez‐Vita, J., Sánchez‐López, E., Carvajal, G., & Egido, J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi265 · Cited by 356 · see citing works

Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor

Wu, K., Li, W., Peng, G., & Li, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908837106 · Cited by 355 · see citing works

Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles

Zisman, L. S., Keller, R. S., Weaver, B. A., Lin, Q., Speth, R. C., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308 · see citing works

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Yang, P., Gu, H., Zhao, Z., Wang, W., Cao, B., Lai, C., Yang, X., Zhang, L., Duan, Y., Zhang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07027 · Cited by 283 · see citing works

What’s new in the renin-angiotensin system?

Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4242-5 · Cited by 250 · see citing works

ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition

Perlot, T., & Penninger, J. M. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.08.003 · Cited by 242 · see citing works

Cellular entry of the SARS coronavirus

Hofmann, H., & Pöhlmann, S. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.08.008 · Cited by 238 · see citing works

The Nef Protein of Human Immunodeficiency Virus Establishes Superinfection Immunity by a Dual Strategy to Downregulate Cell-Surface CCR5 and CD4

Michel, N., Allespach, I., Venzke, S., Fackler, O., & Keppler, O. T. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.058 · Cited by 221 · see citing works

Trend and forecasting of the COVID-19 outbreak in China

Li, Q., Feng, W., & Quan, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.014 · Cited by 169 · see citing works

ACE and ACE2 in Inflammation: A Tale of Two Enzymes

Gaddam, R. R., Chambers, S. T., & Bhatia, M. (2014) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528113666140713164506 · Cited by 163 · see citing works

Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients

Huang, F., Guo, J., Zou, Z., Liu, J., Cao, B., Zhang, S., Li, H., Wang, W., Sheng, M., Liu, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4595 · Cited by 150 · see citing works

Lessons from SARS: control of acute lung failure by the SARS receptor ACE2

Kuba, K., Imai, Y., Rao, S., Jiang, C., & Penninger, J. M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0094-9 · Cited by 135 · see citing works

Two Things about COVID-19 Might Need AttentionPreprint

Jia, X., Yin, C., Lu, S., Chen, Y., Liu, Q., Bai, J., & Lu, Y. (2020) · Preprints.org · doi:10.20944/preprints202002.0315.v1 · Cited by 134 · see citing works

Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV

Li, R., Qiao, S., & Zhang, G. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.013 · Cited by 125 · see citing works

Age-Dependent Changes in the Pulmonary Renin-Angiotensin System Are Associated With Severity of Lung Injury in a Model of Acute Lung Injury in Rats

Schouten, L. R. A., Helmerhorst, H. J. F., Wagenaar, G. T. M., Haltenhof, T., Lutter, R., Roelofs, J. J. T. H., van Woensel, J. B. M., van Kaam, A. H., Bos, A. P., Schultz, M. J., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000002008 · Cited by 64 · see citing works

Membrane ectopeptidases targeted by human coronaviruses

Bosch, B., Smits, S. L., & Haagmans, B. L. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.03.011 · Cited by 51 · see citing works

Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse

Yan, Y., Liu, Q., Li, N., Du, J., Li, X., Li, C., Jin, N., & Jiang, C. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4814-7 · Cited by 43 · see citing works

Interaction Between the Spike Protein of Human Coronavirus NL63 and its Cellular Receptor ACE2

Pöhlmann, S., Gramberg, T., Wegele, A., Pyrć, K., van der Hoek, L., Berkhout, B., & Hofmann, H. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-33012-9_47 · Cited by 26 · see citing works

A comprehensive review of COVID-19 characteristics

Esakandari, H., Nabi‐Afjadi, M., Afjadi, J. F., Farahmandian, N., Miresmaeili, S. M., & Bahreini, E. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00128-2 · Cited by 511 · see citing works

Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions

Jafarzadeh, A., Chauhan, P. S., Saha, B., Jafarzadeh, S., & Nemati, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118102 · Cited by 327 · see citing works

Perspective: Vitamin D deficiency and COVID‐19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis

Rhodes, J. M., Subramanian, S., Laird, E. J., Griffin, G. E., & Kenny, R. A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13149 · Cited by 240 · see citing works

What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses

Gadi, N., Wu, S., Spihlman, A. P., & Moulton, V. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02147 · Cited by 185 · see citing works

Asthma among hospitalized patients with COVID-19 and related outcomes

Lovinsky‐Desir, S., Deshpande, D., De, A., Murray, L. P., Stingone, J. A., Chan, A., Patel, N. N., Rai, N., DiMango, E., Milner, J. D., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.026 · Cited by 137 · see citing works

Impact of COVID-19 pandemic on chronic pain management: Looking for the best way to deliver care

Puntillo, F., Giglio, M., Brienza, N., Viswanath, O., Urits, I., Kaye, A. D., Pergolizzi, J. V., Paladini, A., & Varrassi, G. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.07.001 · Cited by 102 · see citing works

Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity

Pasquarelli-do-Nascimento, G., Braz-de-Melo, H. A., Faria, S. S., Santos, I. D. O., Kobinger, G., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00530 · Cited by 99 · see citing works

Cognitive decline following acute viral infections: literature review and projections for post-COVID-19

Damiano, R. F., Guedes, B. F., de Rocca, C. C., de Pádua Serafim, A., Castro, L. H. M., Munhoz, C. D., Nitrini, R., Filho, G. B., Miguel, E. C., Lucchetti, G., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01286-4 · Cited by 98 · see citing works

ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease

Kuriakose, J., Montezano, A. C. I., & Touyz, R. M. (2021) · Clinical Science · doi:10.1042/cs20200480 · Cited by 79 · see citing works

Severe COVID-19: what have we learned with the immunopathogenesis?

Corrêa, B. B., Rodrigues, M. B., Cortez, A. F., Vieira, M., & Pinheiro, M. M. (2020) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-020-00151-7 · Cited by 78 · see citing works

Diabetes mellitus and COVID-19: Understanding the association in light of current evidence

Sen, S., Chakraborty, R., Kalita, P., & Pathak, M. P. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i28.8327 · Cited by 73 · see citing works

Proper Management of People with Obesity during the COVID-19 Pandemic

Lim, S. K., Shin, S. M., Nam, G. E., Jung, C. H., & Koo, B. K. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20056 · Cited by 71 · see citing works

Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)

McCreary, M. R., Schnell, P., & Rhoda, D. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-13920-9 · Cited by 68 · see citing works

A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study

Wang, Z., Li, K., Maskey, A., Huang, W., Toutov, A. A., Yang, N., Srivastava, K. D., Geliebter, J., Tiwari, R. K., Miao, M., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001792r · Cited by 66 · see citing works

Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

Pedrosa, M. A., Valenzuela, R., Garrido‐Gil, P., Labandeira, C. M., Navarro, G., Franco, R., Labandeira-García, J. L., & Rodriguez-Perez, A. I. (2021) · Clinical Science · doi:10.1042/cs20201511 · Cited by 66 · see citing works

ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection

Descamps, G., Verset, L., Trelcat, A., Hopkins, C. L., Lechien, J. R., Journé, F., & Saussez, S. (2020) · Biology · doi:10.3390/biology9080235 · Cited by 64 · see citing works

Microbiota and COVID-19: Long-term and complex influencing factors

Gang, J., Wang, H., Xue, X., & Zhang, S. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.963488 · Cited by 61 · see citing works

Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation

Augustine, R., Abhilash, S., Nayeem, A., Salam, S. A., Augustine, P., Dan, P., Maureira, P., Mraiche, F., Gentile, C., Hansbro, P. M., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109738 · Cited by 53 · see citing works

Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection

Chang, T., Yang, J., Deng, H., Chen, D., Yang, X., & Tang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843342 · Cited by 52 · see citing works

Effect of Biomedical Materials in the Implementation of a Long and Healthy Life Policy

Dobrzański, L. A., Dobrzańska-Danikiewicz, A. D., & Dobrzański, L. B. (2021) · Processes · doi:10.3390/pr9050865 · Cited by 51 · see citing works

Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit

Madia, F., Merico, B., Primiano, G., Cutuli, S. L., PASCALE, G. D., & Servidei, S. (2020) · Neurology · doi:10.1212/wnl.0000000000010280 · Cited by 50 · see citing works

Repurposing existing drugs for COVID-19: an endocrinology perspective

Cadegiani, F. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00626-0 · Cited by 45 · see citing works

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

Valenzuela, R., Rodriguez-Perez, A. I., Costa-Besada, M. A., Rivas‐Santisteban, R., Garrido‐Gil, P., López-López, A., Navarro, G., Lanciego, J. L., Franco, R., & Labandeira-García, J. L. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102078 · Cited by 43 · see citing works

Exercise as medicine for COVID-19: An ACE in the hole?

Heffernan, K. S., & Jae, S. Y. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109835 · Cited by 40 · see citing works

The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois

Udoakang, A. J., Zune, A. L. D., Tapela, K., Nganyewo, N. N., Olisaka, F. N., Anyigba, C. A., Tawiah-Eshun, S., Owusu, I. A., Paemka, L., Awandare, G. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104828 · Cited by 40 · see citing works

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients

Cadegiani, F., Goren, A., Wambier, C. G., & McCoy, J. M. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100915 · Cited by 38 · see citing works

An Immune Epigenetic Insight to COVID-19 Infection

Jit, B. P., Qazi, S., Arya, R. K., Srivastava, A., Gupta, N., & Sharma, A. K. (2021) · Epigenomics · doi:10.2217/epi-2020-0349 · Cited by 37 · see citing works

Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications

Ning, L., Rong, J., Zhang, Z., & Xu, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105409 · Cited by 36 · see citing works

Impact of SARS-CoV-2 on Male Reproductive Health: A Review of the Literature on Male Reproductive Involvement in COVID-19

He, W., Liu, X., Feng, L., Xiong, S., Li, Y., Chen, L., Yu, L., Wang, G., Li, D., & Fu, B. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594364 · Cited by 34 · see citing works

Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury

Biscetti, F., Rando, M. M., Nardella, E., Cecchini, A. L., Bruno, P., Landolfi, R., & Flex, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218141 · Cited by 32 · see citing works

Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19

Олеговна, Ш. П., As, B., Свитич, О. А., & Зверев, В. В. (2020) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2020-97-4-6 · Cited by 31 · see citing works

Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities

Yan, T., Xiao, R., Wang, N., Shang, R., & Lin, G. (2021) · Theranostics · doi:10.7150/thno.59293 · Cited by 30 · see citing works

Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2

Mohammad, A., Marafie, S. K., ALSHAWAF, E. M. M., Abu‐Farha, M., Abubaker, J. A., & Al‐Mulla, F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118219 · Cited by 28 · see citing works

Sex differences in clinical characteristics and risk factors for mortality among severe patients with COVID-19: a retrospective study

Su, W., Qiu, Z., Zhou, L., Hou, J., Wang, Y., Huang, F., Zhang, Y., Jia, Y., Zhou, J., Liu, D., et al. (2020) · Aging · doi:10.18632/aging.103793 · Cited by 28 · see citing works

Ozone Therapy as a Possible Option in COVID-19 Management

Gavazza, A., Marchegiani, A., Rossi, G., Franzini, M., Spaterna, A., Mangiaterra, S., & Cerquetella, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00417 · Cited by 26 · see citing works

Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters

Sencio, V., Benech, N., Robil, C., Deruyter, L., Heumel, S., Machelart, A., Sulpice, T., Lamazière, A., Grangette, C., Briand, F., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2100200 · Cited by 25 · see citing works

D‐dimer levels is associated with severe COVID‐19 infections: A meta‐analysis

Du, W., Zhang, Y., Yu, Y., & Zhang, R. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14031 · Cited by 23 · see citing works

A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targets

Khan, A. T.-A., Khalid, Z., Zahid, H., Yousaf, M. A., & Shakoori, A. R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1833760 · Cited by 23 · see citing works

Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex

Isaac-Lam, M. F. (2021) · In Silico Pharmacology · doi:10.1007/s40203-021-00114-w · Cited by 23 · see citing works

ACE2 polymorphisms impact COVID-19 severity in obese patients

Jalaleddine, N., Bouzid, A., Hachim, M. Y., Sharif‐Askari, N. S., Mahboub, B. H., Senok, A. C., Halwani, R., Hamoudi, R., & Heialy, S. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26072-7 · Cited by 22 · see citing works

Structural variations and expression profiles of the SARS‐CoV‐2 host invasion genes in lung cancer

Sağkan, R. I., & Akın, D. F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26107 · Cited by 22 · see citing works

Estatinas en COVID-19: ¿existe algún fundamento?

Martínez, M. M. L., Contreras, M. A., Marín, W., & D’Marco, L. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.06.003 · Cited by 21 · see citing works

Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study

Yahyavi, A., Hemmati, N., Derakhshan, P., Banivaheb, B., Behnagh, A. K., Tofighi, R., TehraniYazdi, A., & Kabir, A. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02523-9 · Cited by 21 · see citing works

Relevance of VEGF and CD147 in different SARS‐CoV‐2 positive digestive tracts characterized by thrombotic damage

Bortolotti, D., Simioni, C., Neri, L. M., Rizzo, R., Semprini, C. M., Occhionorelli, S., Laface, I., Sanz, J. M., Schiuma, G., Rizzo, S., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100821rrr · Cited by 20 · see citing works

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment

Labandeira-García, J. L., Labandeira, C. M., Valenzuela, R., Pedrosa, M. A., Quijano, A., & Rodriguez-Perez, A. I. (2022) · Biomedicines · doi:10.3390/biomedicines10020502 · Cited by 20 · see citing works

ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity

Triposkiadis, F. K., Xanthopoulos, A. V., Giamouzis, G., Boudoulas, K. D., Starling, R. C., Skoularigis, J. S., Boudoulas, H. K., & Iliodromitis, E. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173885 · Cited by 18 · see citing works

Effects of physical activity on the severity of illness and mortality in COVID-19 patients: A systematic review and meta-analysis

Sittichai, N., Parasin, N., Saokaew, S., Kanchanasurakit, S., Kayod, N., Praikaew, K., Phisalprapa, P., & Prasannarong, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1030568 · Cited by 17 · see citing works

Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options

Dessie, G., & Malik, T. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s308176 · Cited by 17 · see citing works

SARS-CoV-2 and the cardiovascular system

Hafiane, A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.019 · Cited by 16 · see citing works

Study on the Clinical Significance of ACE2 and Its Age-Related Expression

Gu, J., Yin, J., Zhang, M., Li, J., Wu, Y., Chen, J., & Miao, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s315981 · Cited by 16 · see citing works

Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.Preprint

Cadegiani, F., Goren, A., Wambier, C. G., & McCoy, J. M. (2020) · doi:10.21203/rs.3.rs-100994/v1 · Cited by 16 · see citing works

Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection

Vargas-Rodríguez, J. R., Veloz, I. G., Flores‐Morales, V., Badillo-Almaraz, J. I., Rocha-Pizaña, M. D. R., Valdés-Aguayo, J. J., & Martínez‐Fierro, M. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.758414 · Cited by 14 · see citing works

The Good, The Bad and The Ugly: A Mathematical Model Investigates the Differing Outcomes Among CoVID-19 Patients

Sahoo, S., Jhunjhunwala, S., Jolly, M. K., & Jolly, M. K. (2020) · Journal of the Indian Institute of Science · doi:10.1007/s41745-020-00205-1 · Cited by 22 · see citing works

Statins in COVID-19: Is there any foundation?

Martínez, M. M. L., Contreras, M. A., Marín, W., & D’Marco, L. (2020) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2020.11.004 · Cited by 13 · see citing works

Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters

Briand, F., Sencio, V., Robil, C., Heumel, S., Deruyter, L., Machelart, A., Barthelemy, J., Bogard, G., Hoffmann, E., Infanti, F., et al. (2022) · Viruses · doi:10.3390/v14092067 · Cited by 12 · see citing works

ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury

Lin, C., Chen, Y., Lin, M. C., Chang, H.-J., Yang, X., & Lin, C. (2023) · Medicina · doi:10.3390/medicina59091554 · Cited by 11 · see citing works

Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2

Elrashdy, F., Redwan, E. M., & Uversky, V. N. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104510 · Cited by 11 · see citing works

Lung Expression of Macrophage Markers CD68 and CD163, Angiotensin Converting Enzyme 2 (ACE2), and Caspase-3 in COVID-19

Ziablitsev, D. S., Kozyk, M., Strubchevska, K., Dyadyk, O. O., & Ziablitsev, S. V. (2023) · Medicina · doi:10.3390/medicina59040714 · Cited by 11 · see citing works

One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19

Yu, Y., Fang, B., Yang, X., & Zheng, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1185076 · Cited by 10 · see citing works

Repurposing current therapeutic regimens against SARS-CoV-2 (Review)

Konstantinidou, S. M., & Papanastasiou, I. P. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8905 · Cited by 10 · see citing works

No association between use of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID‐19 in the COvid MEdicaTion (COMET) study

Sablerolles, R. S. G., Hogenhuis, F. E. F., Lafeber, M., van de Loo, B. P. A., Borgsteede, S. D., Boersma, E. H., Versmissen, J., & van der Kuy, P. H. M. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14751 · Cited by 10 · see citing works

Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers

Grant, W. B. (2024) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2023.12.007 · Cited by 9 · see citing works

Relevance between COVID-19 and host genetics of immune response

Taher, I., Almaeen, A. H., Ghazy, A. A., Abu‐Farha, M., Channanath, A. M., John, S. E., Hebbar, P., Arefanian, H., Abubaker, J. A., Al‐Mulla, F., et al. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.037 · Cited by 9 · see citing works

Die frühe Phase der COVID-19-Pandemie in Bayern

Wjst, M. (2020) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1286-0212 · Cited by 8 · see citing works

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases

Zhang, Y., Wang, M., Zhang, X., Liu, T., Libby, P., & Shi, G.-P. (2021) · Cardiology Discovery · doi:10.1097/cd9.0000000000000038 · Cited by 8 · see citing works

Radial Peripapillary Capillary Plexus Perfusion and Endothelial Dysfunction in Early Post-SARS-CoV-2 Infection

Savastano, M. C., Santoro, L., Crincoli, E., Fossataro, C., Gambini, G., Savastano, A., Vico, U. D., Santoliquido, A., Nesci, A., Landi, F., et al. (2022) · Vision · doi:10.3390/vision6020026 · Cited by 8 · see citing works

COVID-19 and Neurological Manifestations

Forero, K. V., Buqaileh, R., Sunderman, C. L., & AbouAlaiwi, W. A. (2023) · Brain Sciences · doi:10.3390/brainsci13081137 · Cited by 8 · see citing works

Neutrophil elastase decreases SARS-CoV-2 spike protein binding to human bronchial epithelia by clipping ACE-2 ectodomain from the epithelial surface

Kummarapurugu, A. B., Hawkridge, A. M., Ma, J., Osei, S., Martin, R., Zheng, S., & Voynow, J. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104820 · Cited by 7 · see citing works

Gestión de la pandemia. Visión del radiólogo

Valdés, P., Rovira, À., Guerrero, J., Rodriguez-Morales, A. J., Rovira, M., & Martínez, C. (2020) · Radiología · doi:10.1016/j.rx.2020.10.004 · Cited by 7 · see citing works

Efficacy of defensins as neutralizing agents against the deadly SARS-CoV-2

Varughese, D., Mohanakumar, K. P., & Rajamma, U. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2041487 · Cited by 6 · see citing works

Nanomedicine for the Diagnosis and Therapy of COVID-19

Wang, Y., Hao, Y., Fa, S., Zheng, W., Yuan, C., & Wang, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.758121 · Cited by 5 · see citing works

Tailoring fluorescent probes for detecting COVID-19 virus in bio-samples and in vivo

Gong, J., Wang, X., Rha, H., Hong, S. J., Wu, J., Zhang, F., Mao, Z., & Kim, J. S. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216824 · Cited by 4 · see citing works

Host variations in SARS-CoV-2 infection

ALTIOK, D., SAVCI, E. Z., ÖZKARA, B., ALKAN, K., NAMDAR, D. S., Tuncer, G., Kilinc, B. R., SUİÇMEZ, E., ÇETİN, G., ÜNAL, S., et al. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2104-67 · Cited by 4 · see citing works

The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions

McVoy, M. A., & Kummarapurugu, A. B. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70721 · Cited by 3 · see citing works

Inequality: The Dangers of Meat Haves and Have-Nots in a Nicotinamide-Adenine-Dinucleotide World

Williams, A. C., & Hill, L. J. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96748 · Cited by 3 · see citing works

COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice

Katsi, V. K., Pavlidis, G., Charalambous, G., Tousoulis, D. M., & Toutouzas, K. P. (2021) · Current Hypertension Reviews · doi:10.2174/1573402117666210121100201 · Cited by 3 · see citing works

From cardiovascular system to brain, the potential protective role of Mas Receptors in COVID-19 infection

Cappelletti, P., Gallo, G., Marino, R., Palaniappan, S., Corbo, M., Savoia, C., & Feligioni, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176061 · Cited by 3 · see citing works

Publishing coronavirology: Peering into peer(less?) review

Pederson, T. (2020) · The FASEB Journal · doi:10.1096/fj.202001592 · Cited by 3 · see citing works

Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.Preprint

Cadegiani, F., Goren, A., McCoy, J. M., & Wambier, C. G. (2020) · doi:10.21203/rs.3.rs-98106/v1 · Cited by 3 · see citing works

Angiotensin Converting Enzyme 2 (ACE2) - A macromolecule and its impact on human reproduction during COVID-19 pandemic

G, G., S., V. A., & Dhama, K. (2022) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2022.10(5).960.977 · Cited by 1 · see citing works

COVID-19 in individuals adapted to aerobic exercise

Tretyakov, A. Y., Захарченко, С. П., Ромасенко, Л. В., Dyatlova, A. V., Zhabskaya, A. V., Ermilov, O. V., Tret'yakov, M. A., & Chentsova, D. D. (2020) · PULMONOLOGIYA · doi:10.18093/0869-0189-2020-30-5-553-560 · Cited by 2 · see citing works

Importancia de los estudios de anatomía patológica en COVID-19

Toscano, A. Á., Bassols, Á. C., & González, J. J. E. (2020) · Medicina Crítica · doi:10.35366/94901 · Cited by 2 · see citing works

ACTIVITY OF ANGIOTENSIN-CONVERSING ENZYME-2 IN ACUTE PULMONARY INFLAMMATION

Ziablitsev, D. S., Dyadyk, O. O., & Ziablitsev, S. V. (2021) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.3.2021.01 · Cited by 1 · see citing works

Characteristics of the radial peripapillary capillary network in patients with COVID-19 based on optical coherence tomography angiography: A literature review

Kal, M., Brzdęk, M., Karska‐Basta, I., Rzymski, P., Pinna, A., & Zarębska‐Michaluk, D. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.07.001 · Cited by 1 · see citing works

Radial Peripapillary Capillary Alterations in COVID-19: Insights from Optical Coherence Tomography Angiography – A Systematic Review

Loutroukis, T., Moore, P. D., & Kuchen, R. (2025) · Bulletin of pioneering researches of medical and clinical science · doi:10.51847/wgioepd65q · Cited by 1 · see citing works

Animais utilizados em pesquisas de SARS-COV-2 / Animals used in SARS-VOC-2 Research

de Sampaio, F. M. S., MACIEL, W. N. S., Silva, A. M. A., Amorim, D. D. A., Coelho, A. A., da Silva, C. G. L., Silva, M. R. L. E., & Gadelha, M. D. S. V. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n3-004 · Cited by 1 · see citing works

HIF-1a in immune pathogenesis of SARS-CoV-2-pneumonia

Volchkova, E. V., Кузубова, Н. А., Аleksаndrovich, Y. S., & Lebedeva, E. S. (2022) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology202205171 · Cited by 1 · see citing works

Abordagem profilática da nitazoxanida e ivermectina na COVID-19: Sumário de Evidências

Vasques, M. A. A., Rodrigues, G. J., Mamede, M. M. S., Castro, B. D. A., Monteiro, O. L. R., Ribeiro, A. P., Gomes, L. F., & Imoto, A. M. (2020) · Comunicação em Ciências da Saúde · doi:10.51723/ccs.v31isuppl1.693 · Cited by 1 · see citing works

Risk factors and laboratory predictors of severe Coronavirus Disease 2019Preprint

Pan, M., Wang, R., Chen, X., Han, J. H., Li, Q., Miao, M., Rao, J., Huang, J., Yu, L., Xu, Y., et al. (2020) · doi:10.22541/au.159224941.14010679 · Cited by 1 · see citing works

Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers Usage in COVID-19 Illness Leading to Confusion or Conclusion: a Comprehensive Review

(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac113.1081210823

Brave new world an update on COVID-19 pandemic – A review

Gadó, K., Domján, G., & Nagy, Z. Z. (2020) · Developments in Health Sciences · doi:10.1556/2066.2020.00009

Physical Activity May be a Major Deterrent of Severe Health Consequences from COVID-19: An Annotated Summary of Physical Activity and COVID-19 Research

Bonis, M. P. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.29.004733

A novel coronavirus—from basic research to clinic

Luo, D., Wang, T., Tan, Z., Guo, S., Yu, Z., Liu, Y., ZHANG, Y., Wang, B., Gao, Y., Wang, H., et al. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2020-0233

Combined hormonal contraception during a pandemic

Adamyan, L. V., Andreeva, E. N., Stepanian, A. A., & Absatarova, Y. S. (2021) · Russian Journal of Human Reproduction · doi:10.17116/repro20212703223

Пандемія COVID‑19 у дискурсі глобальних еволюційно-екологічних викликів цивілізаційного поступу

Dzeman, M. I. (2021) · Терапевтика · doi:10.31793/2709-7404.2021.2-2.10

Managing the pandemic from the radiology department’s point of view

Valdés, P., Rovira, À., Guerrero, J., Rodriguez-Morales, A. J., Rovira, M., & Martínez, C. (2020) · Radiología (English Edition) · doi:10.1016/j.rxeng.2020.10.001

Insight to SARS-CoV-2 Vaccines Based on Virus Structure and Properties

Basingab, F. S., & Zaher, K. A. (2021) · Pharmacophore · doi:10.51847/fdsqzwy0t3

South African (501Y.V2) and the United Kingdom (B.1.1.7) SARS-CoV-2 Spike (S) Protein Variants Demonstrate a Higher Binding Affinity to ACE2

Mohammad, A., Al‐Mulla, F., & Abubaker, J. A. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220607145225

The role of the renin-angiotensin-aldosterone system in the development of cardiovascular complications in COVID-19

Забежинский, М. М., & Semenova, A. A. (2023) · Pediatrician (St Petersburg) · doi:10.17816/ped14198-118

Manifestações psicopatológicas e cognitivas associadas à infecção pelo vírus SARS-CoV-2

Damiano, R. F. (2023) · doi:10.11606/t.5.2023.tde-29082023-114208

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor

Li, Y., Zhou, W., Li, Y., & You, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104833 · Cited by 378 · see citing works

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?

Hu, Y., Liu, L., & Lu, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725967 · Cited by 21 · see citing works

Angiotensin-converting enzyme 2: angel or evil?

Gironacci, M. M. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19

Restini, C. B. A., Belavek, T., Bernal, R., Ibrahim, V., Irwin, K., Kim, M., & Merlo, C. (2020) · Coronaviruses · doi:10.2174/2666796701999201218141035 · Cited by 3 · see citing works

Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19)

Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G. D. H., Voors, A. A., Osterhaus, A. D. M. E., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,119 · see citing works